Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Immunity
|
June 20, 2024
Autoantibodies inhibit Plasmodium falciparum growth and are associated with protection from clinical malaria
Kelly A Hagadorn, Mary E Peterson, Hemanta Kole, et al.
The New England Journal of Medicine
|
November 1, 2022
Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali
Kassoum Kayentao, Aissata Ongoiba, Anne C Preston, et al.
Science Translational Medicine
|
June 24, 2021
Functional human IgA targets a conserved site on malaria sporozoites
Joshua Tan, Hyeseon Cho, Tossapol Pholcharee, et al.
Nature Medicine
|
June 3, 2025
Anti-sporozoite monoclonal antibody for malaria prevention: secondary efficacy outcome of a phase 2 randomized trial
Jeff Skinner, Kassoum Kayentao, Aissata Ongoiba, et al.
The Journal of Clinical Investigation
|
July 6, 2026
Pharmacokinetics and pharmacodynamics of a long-acting monoclonal antibody against malaria in African adults
Tuan M Tran, Zonghui Hu, Kassoum Kayentao, et al.
Immunity
|
August 6, 2013
Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies
Tongqing Zhou, Jiang Zhu, Xueling Wu, et al.
Nature Medicine
|
October 27, 2020
Increased circulation time of Plasmodium falciparum underlies persistent asymptomatic infection in the dry season
Carolina M Andrade, Hannah Fleckenstein, Richard Thomson-Luque, et al.
Science Translational Medicine
|
September 14, 2021
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
Hyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
Cell
|
July 26, 2024
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5
Lawrence T Wang, Andrew J R Cooper, Brendan Farrell, et al.
Biorxiv : the Preprint Server for Biology
|
April 6, 2021
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants
Hyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Immunity
|
June 20, 2024
Autoantibodies inhibit Plasmodium falciparum growth and are associated with protection from clinical malaria
Kelly A Hagadorn, Mary E Peterson, Hemanta Kole, et al.
The New England Journal of Medicine
|
November 1, 2022
Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali
Kassoum Kayentao, Aissata Ongoiba, Anne C Preston, et al.
Science Translational Medicine
|
June 24, 2021
Functional human IgA targets a conserved site on malaria sporozoites
Joshua Tan, Hyeseon Cho, Tossapol Pholcharee, et al.
Nature Medicine
|
June 3, 2025
Anti-sporozoite monoclonal antibody for malaria prevention: secondary efficacy outcome of a phase 2 randomized trial
Jeff Skinner, Kassoum Kayentao, Aissata Ongoiba, et al.
The Journal of Clinical Investigation
|
July 6, 2026
Pharmacokinetics and pharmacodynamics of a long-acting monoclonal antibody against malaria in African adults
Tuan M Tran, Zonghui Hu, Kassoum Kayentao, et al.
Immunity
|
August 6, 2013
Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies
Tongqing Zhou, Jiang Zhu, Xueling Wu, et al.
Nature Medicine
|
October 27, 2020
Increased circulation time of Plasmodium falciparum underlies persistent asymptomatic infection in the dry season
Carolina M Andrade, Hannah Fleckenstein, Richard Thomson-Luque, et al.
Science Translational Medicine
|
September 14, 2021
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
Hyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
Cell
|
July 26, 2024
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5
Lawrence T Wang, Andrew J R Cooper, Brendan Farrell, et al.
Biorxiv : the Preprint Server for Biology
|
April 6, 2021
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants
Hyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
Page
of 7